Details of Drug-Metabolizing Enzyme (DME)
General Information of DME (ID: DME1257) | |||||
---|---|---|---|---|---|
DME Name | Unclear metabolic mechanism (DME-unclear), Bifidobacterium longum | ||||
Gene Name | DME-unclear | ||||
Lineage | Species: Bifidobacterium longum (Click to Show/Hide the Complete Species Lineage) | ||||
Interactome(loading-time for this interactome depdends on the speed of web connection) | |||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Pathway/Function) of This DME | |||||
Tissue Distribution | Primarily distributed in human gut. | ||||
Full List of Drug(s) Metabolized by This DME | |||||
---|---|---|---|---|---|
Drugs Approved by FDA | Click to Show/Hide the Full List of Drugs: 13 Drugs | ||||
Mycophenolate mofetil |
Drug Info | Approved | Crohn disease | ICD11: DD70 | [1] |
Fluoxetine hydrochloride |
Drug Info | Approved | Depression | ICD11: 6A71 | [1] |
Danazol |
Drug Info | Approved | Endometriosis | ICD11: GA10 | [1] |
Famciclovir |
Drug Info | Approved | Genital herpes | ICD11: 1A94 | [1] |
Omeprazole |
Drug Info | Approved | Gastro-oesophageal reflux disease | ICD11: DA22 | [1] |
Sulfasalazine |
Drug Info | Approved | Rheumatoid arthritis | ICD11: FA20 | [1] |
Lovastatin |
Drug Info | Approved | Hypertriglyceridaemia | ICD11: 5C80 | [2] |
Pantoprazole sodium |
Drug Info | Approved | Gastro-oesophageal reflux disease | ICD11: DA22 | [1] |
Bromocriptine mesylate |
Drug Info | Approved | Parkinsonism | ICD11: 8A00 | [1] |
Entacapone |
Drug Info | Approved | Parkinsonism | ICD11: 8A00 | [1] |
Melphalan |
Drug Info | Approved | Multiple myeloma | ICD11: 2A83 | [1] |
Tinidazole |
Drug Info | Approved | Protozoan infection | ICD11: 1F5Z | [1] |
Olmesartan medoxomil |
Drug Info | Approved | Essential hypertension | ICD11: BA00 | [1] |
Drugs in Phase 4 Clinical Trial | Click to Show/Hide the Full List of Drugs: 3 Drugs | ||||
Artemisinin |
Drug Info | Phase 4 | Malaria | ICD11: 1F40 | [1] |
Racecadotril |
Drug Info | Phase 4 | Irritable bowel syndrome | ICD11: DD91 | [1] |
Bisacodyl |
Drug Info | Phase 4 | Irritable bowel syndrome | ICD11: DD91 | [1] |
Drugs in Phase 2 Clinical Trial | Click to Show/Hide the Full List of Drugs: 2 Drugs | ||||
Roxatidine |
Drug Info | Phase 2 | Gastro-oesophageal reflux disease | ICD11: DA22 | [1] |
TU-199 |
Drug Info | Phase 2 | Gastro-oesophageal reflux disease | ICD11: DA22 | [1] |
Drugs in Phase 1 Clinical Trial | Click to Show/Hide the Full List of Drugs: 2 Drugs | ||||
BE-14348A |
Drug Info | Phase 1 | Viral hepatitis | ICD11: 1E51 | [3] |
BRN-0498823 |
Drug Info | Phase 1 | Essential hypertension | ICD11: BA00 | [1] |
Preclinical/investigative Agents | Click to Show/Hide the Full List of Drugs: 5 Drugs | ||||
AS-63093 |
Drug Info | Preclinical | Allergy | ICD11: 4A80 | [3] |
Diacetamate |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [1] |
Dihydro-coumaric acid |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [3] |
FT-0669759 |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [3] |
Phloretic acid |
Drug Info | Investigative | Discovery agent | ICD: N.A. | [3] |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.